Indications
Open Access TIMES Journals
Login
Register
Login
Register
Indications
Oncology · Hematology
Cardiovascular
Diabetes + Endocrinology
Pneumology
Ophthalmology
Gynecology · Urology
Dermatology · Immunology · Rheumatology
Neurology · Psychiatry
Gastroenterology
Infectiology · Anesthesiology · Pain
Primary Care
Open Access TIMES Journals
Oncology · Hematology
Cardiovascular
Diabetes + Endocrinology
Pneumology
Ophthalmology
Gynecology · Urology
Dermatology · Immunology · Rheumatology
Neurology · Psychiatry
Gastroenterology
Infectiology · Anesthesiology · Pain
Primary Care
Gynecology · Urology
Case Reports
Expert Opinions
Webinar
Faculty
Homepage
>
Gynecology · Urology
>
Articles
Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer
Uro-Oncology
Share:
Related content
Overactive Bladder
Uro-Oncology
Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non-muscle-invasive Bladder Cancer
Eur Urol Focus.
Tabayoyong WB, Kamat AM, O'Donnell MA, McKiernan JM, Ray-Zack MD, Palou J, Brausi M, Black PC, Williams SB
doi: 10.1016/j.euf.2018.08.019.
Uro-Oncology
Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guérin
Eur Urol.
Li R, Sundi D, Zhang J, Kim Y, Sylvester RJ, Spiess PE, Poch MA, Sexton WJ, Black PC, McKiernan JM, Steinberg GD, Kamat AM, Gilbert SM
doi: 10.1016/j.eururo.2020.02.012.
Overactive Bladder
Uro-Oncology
Pregnancy and Childbirth
Palliative Chemotherapy for Bladder Cancer: Treatment Delivery and Outcomes in the General Population
Clin Genitourin Cancer.
Robinson AG, Wei X, Vera-Badillo FE, Mackillop WJ, Booth CM
doi: 10.1016/j.clgc.2016.12.025.
Overactive Bladder
Uro-Oncology
An immediate, single intravesical instillation of mitomycin C is of benefit in patients with non-muscle-invasive bladder cancer irrespective of prognostic risk groups
Urol Oncol.
Bosschieter J, Nieuwenhuijzen JA, Vis AN, van Ginkel T, Lissenberg-Witte BI, Beckers GMA, van Moorselaar RJA
doi: 10.1016/j.urolonc.2018.05.026.
Overactive Bladder
Uro-Oncology
Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients
Eur Urol.
Bosschieter J, Nieuwenhuijzen JA, van Ginkel T, Vis AN, Witte B, Newling D, Beckers GMA, van Moorselaar RJ
doi: 10.1016/j.eururo.2017.06.038.
Uro-Oncology
No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study
World J Urol.
Jerlström T, Chen R, Liedberg F, Andrén O, Ströck V, Aljabery FAS, Hosseini A, Sherif A, Malmström PU, Ullén A, Gårdmark T, Fall K
doi: 10.1007/s00345-019-02770-2
Further Publications Urology
What influences adherence to guidance for post-operative instillation of intravesical chemotherapy to bladder cancer patients?
BJU Int
Dunsmore J, Duncan E, Mariappan P, de Bruin M, MacLennan S, Dimitropoulos K, Kasivisvanathan V, Mostafid H, Briganti A, N'Dow J, MacLennan S
doi: 10.1111/bju.15336
Uro-Oncology
Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme
Eur Urol.
Mariappan P, Johnston A, Padovani L, Clark E, Trail M, Hamid S, Hollins G, Simpson H, Thomas BG, Hasan R, Bhatt J, Ahmad I, Nandwani GM, Mitchell IDC, Hendry D, for members of the Scottish Bladder Cancer QPI Research Collaborative
doi: 10.1016/j.eururo.2020.06.051.
Uro-Oncology
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
Eur Urol.
Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Escrig JLD, Hernández V, Peyronnet B, Seisen T, Soukup V
doi: 10.1016/j.eururo.2019.08.016.